Academic Technology Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Academic Technology Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Academic Technology Ventures Today - Breaking & Trending Today

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial | Lifestyle Behaviors | JAMA

Published: February 28, 2023

This clinical trial compares the efficacy and adverse event profiles of once-weekly subcutaneous semaglutide, 2.4 mg, vs once-daily subcutaneous liraglutide, 3.

Source: jamanetwork.com

Related Topics:

Eteläuomen LäiUnited StatesDomenicam RubinoJenny CraigNovmeta PharmaSophie WaltonGedeon Richter PharmaEli LillyNovo NordiskSpirit Medical Communications GroupEndocrine SocietyJazz PharmaceuticalsBoehringer IngelheimAmerican Diabetes AssociationWashington CenterDr Reddy LabAcademic Technology VenturesNutrition CorpSlim Health NutritionGroup InformationInternational Conference On Harmonization Good Clinical PracticeDrug AdministrationObesity SocietyGedeon RichterWw International